Unlocking access: a comprehensive analysis of medicines accessibility for rare diseases in Thailand
To address these issues, the study recommended accelerating the approval process for rare disease medicines, expanding health insurance coverage, establishing financial support for patients, and creating a specific pricing policy for orphan drugs. Collaborative efforts among stakeholders were emphasized as crucial for improving access to essential medicines and enhancing treatment outcomes for patients with rare diseases in Thailand.
Authors
- Siriwat Suwattanapreeda
- Kusawadee Maluangnon (ORCID: https://orcid.org/0000-0001-9875-561X)
- Sanita Hirunrassamee (ORCID: https://orcid.org/0009-0002-4165-3123)
- Chaoncin Sooksriwong (ORCID: https://orcid.org/0000-0002-6188-882X)
- Thirapich Chuachantra
- Krissana Kuchaisit
- Niti Osirisakul
Institutions
- Thammasat University (TH)
- Ministry of Public Health (TH)
- Ramathibodi Hospital (TH)
- Somdet Chaopraya Institute of Psychiatry (TH)
Publication Details
- Journal
- Orphanet Journal of Rare Diseases
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1186/s13023-025-03754-9
- Citations
- 1
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 3.13